These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7657851)

  • 1. Effect of timing of food on absorption of cefpodoxime proxetil.
    Borin MT; Driver MR; Forbes KK
    J Clin Pharmacol; 1995 May; 35(5):505-9. PubMed ID: 7657851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of food on absorption of cefpodoxime proxetil oral suspension in adults.
    Borin MT; Forbes KK
    Antimicrob Agents Chemother; 1995 Jan; 39(1):273-5. PubMed ID: 7695323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The bioavailability of cefpodoxime proxetil tablets relative to an oral solution.
    Borin MT; Forbes KK; Hughes GS
    Biopharm Drug Dispos; 1995 May; 16(4):295-302. PubMed ID: 7548778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of gastric pH and food on the pharmacokinetics of a new oral cephalosporin, cefpodoxime proxetil.
    Hughes GS; Heald DL; Barker KB; Patel RK; Spillers CR; Watts KC; Batts DH; Euler AR
    Clin Pharmacol Ther; 1989 Dec; 46(6):674-85. PubMed ID: 2557183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of the pharmacokinetics of cefpodoxime proxetil.
    Borin MT
    Drugs; 1991; 42 Suppl 3():13-21. PubMed ID: 1726203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of food intake and age on the pharmacokinetics of AS-924, a novel ester-type cephem antibiotic. Comparison with cefpodoxime proxetil.
    Totsuka K; Shimizu K; Mori N; Sugihara T; Sakai A; Yamaji S; Michisuji Y; Shinohara Y; Kubo A; Tokuoka H
    Int J Antimicrob Agents; 2001 Nov; 18(5):463-9. PubMed ID: 11711262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of cefpodoxime proxetil in healthy young and elderly volunteers.
    Borin MT; Ferry JJ; Forbes KK; Hughes GS
    J Clin Pharmacol; 1994 Jul; 34(7):774-81. PubMed ID: 7929873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefpodoxime pharmacokinetics in children: effect of food.
    Kearns GL; Abdel-Rahman SM; Jacobs RF; Wells TG; Borin MT
    Pediatr Infect Dis J; 1998 Sep; 17(9):799-804. PubMed ID: 9779765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability of cefpodoxime proxetil with co-administered acetylcysteine.
    Kees F; Wellenhofer M; Bröhl K; Grobecker H
    Arzneimittelforschung; 1996 Apr; 46(4):435-8. PubMed ID: 8740095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of cefpodoxime proxetil and interactions with an antacid and an H2 receptor antagonist.
    Saathoff N; Lode H; Neider K; Depperman KM; Borner K; Koeppe P
    Antimicrob Agents Chemother; 1992 Apr; 36(4):796-800. PubMed ID: 1354432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic and tolerance studies of cefpodoxime after single- and multiple-dose oral administration of cefpodoxime proxetil.
    Borin MT; Hughes GS; Patel RK; Royer ME; Cathcart KS
    J Clin Pharmacol; 1991 Dec; 31(12):1137-45. PubMed ID: 1761737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentrations of cefpodoxime in plasma and tonsillar tissue after a single oral dose of cefpodoxime proxetil.
    Gehanno P; Andrews JM; Ichou F; Sultan E; Lenfant B
    J Antimicrob Chemother; 1990 Dec; 26 Suppl E():47-51. PubMed ID: 2292530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefpodoxime proxetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.
    Frampton JE; Brogden RN; Langtry HD; Buckley MM
    Drugs; 1992 Nov; 44(5):889-917. PubMed ID: 1280571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concentrations of cefpodoxime in plasma and pleural fluid after a single oral dose of cefpodoxime proxetil.
    Dumont R; Guetat F; Andrews JM; Sultan E; Lenfant B
    J Antimicrob Chemother; 1990 Dec; 26 Suppl E():41-6. PubMed ID: 2292529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and ex vivo susceptibility of cefpodoxime proxetil in patients receiving continuous ambulatory peritoneal dialysis.
    Johnson CA; Ateshkadi A; Zimmerman SW; Hughes GS; Craig WA; Carey PM; Borin MT
    Antimicrob Agents Chemother; 1993 Dec; 37(12):2650-5. PubMed ID: 8109931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of cefpodoxime in young and elderly volunteers after single doses.
    Tremblay D; Dupront A; Ho C; Coussediere D; Lenfant B
    J Antimicrob Chemother; 1990 Dec; 26 Suppl E():21-8. PubMed ID: 2292526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of cefpodoxime in plasma and skin blister fluid following oral dosing of cefpodoxime proxetil.
    Borin MT; Hughes GS; Spillers CR; Patel RK
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1094-9. PubMed ID: 2393268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition of cefpodoxime proxetil in healthy volunteers and patients with impaired renal function.
    St Peter JV; Borin MT; Hughes GS; Kelloway JS; Shapiro BE; Halstenson CE
    Antimicrob Agents Chemother; 1992 Jan; 36(1):126-31. PubMed ID: 1590677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric emptying and the pharmacokinetics of the cephalosporin antibiotic, cefpodoxime proxetil.
    Hughes GS; Heald DL; Patel R; Spillers CR; Batts DH; Euler AR
    Methods Find Exp Clin Pharmacol; 1990 Apr; 12(3):197-204. PubMed ID: 2352449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetic, bacteriological and clinical evaluation of cefpodoxime proxetil in pediatrics].
    Iwai N; Taneda Y; Nakamura H; Miyazu M; Kasai K
    Jpn J Antibiot; 1989 Jul; 42(7):1571-92. PubMed ID: 2810731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.